US Patent Issued to HANMI PHARM. on Aug. 18 for "Pharmaceutical composite formulation comprising proton pump inhibitor and antacid, and method for preparing same" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,618, issued on Aug. 18, was assigned to HANMI PHARM. Co. LTD. (Hwaseong-si, South Korea).

"Pharmaceutical composite formulation comprising proton pump inhibitor and antacid, and method for preparing same" was invented by Hyuk Jun Cho (Uiwang-si, South Korea), Bo Sik Kim (Seoul, South Korea), Ho Taek Im (Paju-si, South Korea) and Yong Il Kim (Gwacheon-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a pharmaceutical composite formulation and a method of preparing the same, the pharmaceutical composite formulation including: a first layer containing, as an active ingredient, a proton pump inhibitor or a pharmaceutically acce...